(MedPage Today) — High-flow oxygen didn’t help patients survive acute hypoxemic respiratory failure better than standard oxygen, the SOHO trial showed.
Mortality at day 28 came out an identical 14.6% in patients randomized to either treatment…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
